INFLUENZA VIRUS REPLICATION INHIBITOR AND USE THEREOF
申请人:Sunshine Lake Pharma Co., Ltd.
公开号:EP3686201A1
公开(公告)日:2020-07-29
Disclosed are a compound as shown in formula (I) as an influenza virus replication inhibitor and a preparation method therefor, a pharmaceutical composition comprising the compound and the use of the compound and pharmaceutical composition thereof in the treatment of influenza.
Ochiai et al., Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1959, vol. 79, p. 537
作者:Ochiai et al.
DOI:——
日期:——
SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS
申请人:Pfizer Inc.
公开号:US20170348313A1
公开(公告)日:2017-12-07
Compounds of the general formula):
processes for the preparation of these compounds, compositions containing these compounds, and the uses of these compounds.
Ochiai; Ikehara, Pharmaceutical Bulletin, 1954, vol. 2, p. 72,76
作者:Ochiai、Ikehara
DOI:——
日期:——
Ochiai; Ikehara, Pharmaceutical Bulletin, 1955, vol. 3, p. 454,458